H. R. 2617—1211 
‘‘(i) The evaluation, which may include through 
the development of relevant capabilities of expertise 
within a State, of the effectiveness of comprehensive 
community-based programs or strategies and statewide 
systems to prevent and reduce underage drinking, 
across the underage years from early childhood to age 
21, such as programs funded and implemented by 
governmental entities, public health interest groups 
and foundations, and alcohol beverage companies and 
trade associations. 
‘‘(ii) Obtaining and reporting more precise informa-
tion than is currently collected on the scope of the 
underage drinking problem and patterns of underage 
alcohol consumption, including improved knowledge 
about the problem and progress in preventing, 
reducing, and treating underage drinking, as well as 
information on the rate of exposure of youth to adver-
tising and other media messages encouraging and 
discouraging alcohol consumption. 
‘‘(iii) The development and identification of evi-
dence-based or evidence-informed strategies to reduce 
underage drinking, which may include through 
translational research. 
‘‘(iv) Improving and conducting public health data 
collection on alcohol use and alcohol-related conditions 
in States, which may include by increasing the use 
of surveys, such as the Behavioral Risk Factor Surveil-
lance System, to monitor binge and excessive drinking 
and related harms among individuals who are at least 
18 years of age, but not more than 20 years of age, 
including harm caused to self or others as a result 
of alcohol use that is not duplicative of research cur-
rently being conducted or supported by the Department 
of Health and Human Services. 
‘‘(B) AUTHORIZATION
OF
APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this paragraph 
$5,000,000 for each of fiscal years 2023 through 2027. 
‘‘(2) NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND 
MEDICINE STUDY.— 
‘‘(A) IN GENERAL.—Not later than 12 months after the 
date of enactment of the Restoring Hope for Mental Health 
and Well-Being Act of 2022, the Secretary shall— 
‘‘(i) contract with the National Academies of 
Sciences, Engineering, and Medicine to study develop-
ments in research on underage drinking and the 
implications of these developments; and 
‘‘(ii) report to the Congress on the results of such 
review. 
‘‘(B) AUTHORIZATION
OF
APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this paragraph 
$500,000 for fiscal year 2023.’’. 
SEC. 1216. GRANTS FOR JAIL DIVERSION PROGRAMS. 
Section 520G of the Public Health Service Act (42 U.S.C. 290bb– 
38) is amended— 
(1) in subsection (a)— 
(A) by striking ‘‘up to 125’’; and
H. R. 2617—1212 
(B) by striking ‘‘tribes and tribal organizations’’ and 
inserting ‘‘Tribes and Tribal organizations’’; 
(2) in subsection (b)(2), by striking ‘‘tribes, and tribal 
organizations’’ and inserting ‘‘Tribes, and Tribal organizations’’; 
(3) in subsection (c)— 
(A) in paragraph (1), by striking ‘‘Indian tribe or tribal 
organization’’ and inserting ‘‘an Indian Tribe or Tribal 
organization, a health facility or program described in sub-
section (a), or a public or nonprofit entity referred to in 
subsection (a)’’; and 
(B) in paragraph (2)(A)— 
(i) in clause (i), by inserting ‘‘peer recovery support 
services,’’ after ‘‘disorder treatment,’’; and 
(ii) in clause (iii), by striking ‘‘tribe, or tribal 
organization’’ and inserting ‘‘Tribe, or Tribal organiza-
tion’’; 
(4) in subsection (e)— 
(A) in the matter preceding paragraph (1), by striking 
‘‘tribe, or tribal organization’’ and inserting ‘‘Tribe, or Tribal 
organization’’; 
(B) in paragraph (3), by inserting ‘‘and paraprofes-
sionals’’ after ‘‘professionals’’; and 
(C) in paragraph (5), by striking ‘‘or arrest’’ and 
inserting ‘‘, arrest, or release’’; 
(5) in subsection (f), by striking ‘‘tribe, or tribal organiza-
tion’’ each place it appears and inserting ‘‘Tribe, or Tribal 
organization’’; 
(6) in subsection (h), by striking ‘‘tribe, or tribal organiza-
tion’’ and inserting ‘‘Tribe, or Tribal organization’’; and 
(7) in subsection (j), by striking ‘‘$4,269,000 for each of 
fiscal years 2018 through 2022’’ and inserting ‘‘$14,000,000 
for each of fiscal years 2023 through 2027’’. 
SEC. 1217. FORMULA GRANTS TO STATES. 
Section 521 of the Public Health Service Act (42 U.S.C. 290cc– 
21) is amended by striking ‘‘2018 through 2022’’ and inserting 
‘‘2023 through 2027’’. 
SEC. 1218. PROJECTS FOR ASSISTANCE IN TRANSITION FROM 
HOMELESSNESS. 
Section 535(a) of the Public Health Service Act (42 U.S.C. 
290cc–35(a)) is amended by striking ‘‘2018 through 2022’’ and 
inserting ‘‘2023 through 2027’’. 
SEC. 1219. GRANTS FOR REDUCING OVERDOSE DEATHS. 
(a) GRANTS.— 
(1) REPEAL OF MAXIMUM GRANT AMOUNT.—Paragraph (2) 
of section 544(a) of the Public Health Service Act (42 U.S.C. 
290dd–3(a)) is hereby repealed. 
(2) ELIGIBLE
ENTITY; SUBGRANTS.—Section 544(a) of the 
Public Health Service Act (42 U.S.C. 290dd–3(a)) is amended 
by striking paragraph (3) and inserting the following: 
‘‘(2) ELIGIBLE ENTITY.—For purposes of this section, the 
term ‘eligible entity’ means a State, Territory, locality, or Indian 
Tribe or Tribal organization (as those terms are defined in 
section 4 of the Indian Self-Determination and Education 
Assistance Act).
H. R. 2617—1213 
‘‘(3) SUBGRANTS.—For the purposes for which a grant is 
awarded under this section, the eligible entity receiving the 
grant may award subgrants to a Federally qualified health 
center (as defined in section 1861(aa) of the Social Security 
Act), an opioid treatment program (as defined in section 8.2 
of title 42, Code of Federal Regulations (or any successor regula-
tions)), any practitioner dispensing narcotic drugs pursuant 
to section 303(g) of the Controlled Substances Act, or any 
nonprofit organization that the Secretary deems appropriate, 
which may include Urban Indian organizations (as defined 
in section 4 of the Indian Health Care Improvement Act).’’. 
(3) PRESCRIBING.—Section 544(a)(4) of the Public Health 
Service Act (42 U.S.C. 290dd–3(a)(4)) is amended— 
(A) in subparagraph (A), by inserting ‘‘, including 
patients prescribed both an opioid and a benzodiazepine’’ 
before the semicolon at the end; and 
(B) in subparagraph (D), by striking ‘‘drug overdose’’ 
and inserting ‘‘overdose’’. 
(4) USE OF FUNDS.—Paragraph (5) of section 544(c) of the 
Public Health Service Act (42 U.S.C. 290dd–3(c)) is amended 
to read as follows: 
‘‘(5) To establish protocols to connect patients who have 
experienced an overdose with appropriate treatment, including 
overdose reversal medications, medication assisted treatment, 
and appropriate counseling and behavioral therapies.’’. 
(5) IMPROVING ACCESS TO OVERDOSE TREATMENT.—Section 
544 of the Public Health Service Act (42 U.S.C. 290dd–3) is 
amended— 
(A) by redesignating subsections (d) through (f) as sub-
sections (e) through (g), respectively; 
(B) in subsection (f), as so redesignated, by striking 
‘‘subsection (d)’’ and inserting ‘‘subsection (e)’’; and 
(C) by inserting after subsection (c) the following: 
‘‘(d) IMPROVING ACCESS TO OVERDOSE TREATMENT.— 
‘‘(1) INFORMATION ON BEST PRACTICES.— 
‘‘(A) HEALTH AND HUMAN SERVICES.—The Secretary of 
Health and Human Services may provide information to 
States, localities, Indian Tribes, Tribal organizations, and 
Urban Indian organizations on best practices for pre-
scribing or co-prescribing a drug or device approved, 
cleared, or otherwise legally marketed under the Federal 
Food, Drug, and Cosmetic Act for emergency treatment 
of known or suspected opioid overdose, including for 
patients receiving chronic opioid therapy and patients being 
treated for opioid use disorders. 
‘‘(B) DEFENSE.—The Secretary of Health and Human 
Services may, as appropriate, consult with the Secretary 
of Defense regarding the provision of information to pre-
scribers within Department of Defense medical facilities 
on best practices for prescribing or co-prescribing a drug 
or device approved, cleared, or otherwise legally marketed 
under the Federal Food, Drug, and Cosmetic Act for emer-
gency treatment of known or suspected opioid overdose, 
including for patients receiving chronic opioid therapy and 
patients being treated for opioid use disorders. 
‘‘(C) VETERANS AFFAIRS.—The Secretary of Health and 
Human Services may, as appropriate, consult with the
H. R. 2617—1214 
Secretary of Veterans Affairs regarding the provision of 
information to prescribers within Department of Veterans 
Affairs medical facilities on best practices for prescribing 
or co-prescribing a drug or device approved, cleared, or 
otherwise legally marketed under the Federal Food, Drug, 
and Cosmetic Act for emergency treatment of known or 
suspected opioid overdose, including for patients receiving 
chronic opioid therapy and patients being treated for opioid 
use disorders. 
‘‘(2) RULE OF CONSTRUCTION.—Nothing in this subsection 
shall be construed as establishing or contributing to a medical 
standard of care.’’. 
(6) AUTHORIZATION OF APPROPRIATIONS.—Section 544(g) of 
the Public Health Service Act (42 U.S.C. 290dd–3(g)), as 
redesignated, is amended by striking ‘‘fiscal years 2017 through 
2021’’ and inserting ‘‘fiscal years 2023 through 2027’’. 
(7) TECHNICAL AMENDMENTS.— 
(A) Section 544 of the Public Health Service Act (42 
U.S.C. 290dd–3), as amended, is further amended by 
striking ‘‘approved or cleared’’ each place it appears and 
inserting ‘‘approved, cleared, or otherwise legally mar-
keted’’. 
(B) Section 107 of the Comprehensive Addiction and 
Recovery Act of 2016 (Public Law 114–198) is amended 
by striking subsection (b). 
SEC. 1220. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND 
EDUCATION GRANT PROGRAMS. 
(a) GRANTS.—Section 545 of the Public Health Service Act 
(42 U.S.C. 290ee) is amended— 
(1) in the section heading, by striking ‘‘ACCESS AND EDU-
CATION GRANT PROGRAMS’’ and inserting ‘‘ACCESS, EDUCATION, 
AND CO-PRESCRIBING GRANT PROGRAMS’’; 
(2) in the heading of subsection (a), by striking ‘‘GRANTS 
TO STATES’’ and inserting ‘‘GRANTS’’; 
(3) in subsection (a), by striking ‘‘shall make grants to 
States’’ and inserting ‘‘shall make grants to States, localities, 
Indian Tribes, and Tribal organizations (as those terms are 
defined in section 4 of the Indian Self-Determination and Edu-
cation Assistance Act)’’; 
(4) in subsection (a)(1), by striking ‘‘implement strategies 
for pharmacists to dispense a drug or device’’ and inserting 
‘‘implement strategies that increase access to drugs or devices’’; 
(5) by redesignating paragraphs (3) and (4) as paragraphs 
(4) and (5), respectively; and 
(6) by inserting after paragraph (2) the following: 
‘‘(3) encourage health care providers to co-prescribe, as 
appropriate, drugs or devices approved, cleared, or otherwise 
legally marketed under the Federal Food, Drug, and Cosmetic 
Act for emergency treatment of known or suspected opioid 
overdose;’’. 
(b) GRANT PERIOD.—Section 545(d)(2) of the Public Health 
Service Act (42 U.S.C. 290ee(d)(2)) is amended by striking ‘‘3 years’’ 
and inserting ‘‘5 years’’. 
(c) LIMITATION.—Paragraph (3) of section 545(d) of the Public 
Health Service Act (42 U.S.C. 290ee(d)) is amended to read as 
follows:
H. R. 2617—1215 
‘‘(3) LIMITATIONS.—A State may— 
‘‘(A) use not more than 10 percent of a grant under 
this section for educating the public pursuant to subsection 
(a)(5); and 
‘‘(B) use not less than 20 percent of a grant under 
this section to offset cost-sharing for distribution and dis-
pensing of drugs or devices approved, cleared, or otherwise 
legally marketed under the Federal Food, Drug, and Cos-
metic Act for emergency treatment of known or suspected 
opioid overdose.’’. 
(d) AUTHORIZATION OF APPROPRIATIONS.—Section 545(h)(1) of 
the Public Health Service Act, is amended by striking ‘‘fiscal years 
2017 through 2019’’ and inserting ‘‘fiscal years 2023 through 2027’’. 
(e) TECHNICAL AMENDMENT.—Section 545 of the Public Health 
Service Act (42 U.S.C. 290ee), as amended, is further amended 
by striking ‘‘approved or cleared’’ each place it appears and inserting 
‘‘approved, cleared, or otherwise legally marketed’’. 
SEC. 1221. EMERGENCY DEPARTMENT ALTERNATIVES TO OPIOIDS. 
Section 7091 of the SUPPORT for Patients and Communities 
Act (Public Law 115–271) is amended— 
(1) in the section heading, by striking ‘‘DEMONSTRATION’’ 
(and by conforming the item relating to such section in the 
table of contents in section 1(b)); 
(2) in subsection (a)— 
(A) by amending the subsection heading to read as 
follows: ‘‘GRANT PROGRAM’’; and 
(B) in paragraph (1), by striking ‘‘demonstration’’; 
(3) in subsection (b), in the subsection heading, by striking 
‘‘DEMONSTRATION’’; 
(4) in subsection (d)(4), by striking ‘‘tribal’’ and inserting 
‘‘Tribal’’; 
(5) in subsection (f)— 
(A) in the heading, by striking ‘‘REPORT’’ and inserting 
‘‘REPORTS’’; and 
(B) in the matter preceding paragraph (1), by striking 
‘‘Not later than 1 year after completion of the demonstra-
tion program under this section, the Secretary shall submit 
a report to the Congress on the results of the demonstration 
program’’ and inserting ‘‘Not later than the end of each 
of fiscal years 2024 and 2027, the Secretary shall submit 
to the Committee on Health, Education, Labor, and Pen-
sions of the Senate and the Committee on Energy and 
Commerce of the House of Representatives a report on 
the results of the program’’; and 
(6) in subsection (g), by striking ‘‘2019 through 2021’’ and 
inserting ‘‘2023 through 2027’’. 
CHAPTER 3—EXCELLENCE IN RECOVERY HOUSING 
SEC. 1231. CLARIFYING THE ROLE OF SAMHSA IN PROMOTING THE 
AVAILABILITY OF HIGH-QUALITY RECOVERY HOUSING. 
Section 501(d) of the Public Health Service Act (42 U.S.C. 
290aa) is amended— 
(1) in paragraph (24)(E), by striking ‘‘and’’ at the end; 
(2) in paragraph (25), by striking the period at the end 
and inserting ‘‘; and’’; and
H. R. 2617—1216 
(3) by adding at the end the following: 
‘‘(26) collaborate with national accrediting entities, recovery 
housing providers, organizations or individuals with established 
expertise in delivery of recovery housing services, States, Fed-
eral agencies (including the Department of Health and Human 
Services, the Department of Housing and Urban Development, 
and the agencies listed in section 550(e)(2)(B)), and other rel-
evant stakeholders, to promote the availability of high-quality 
recovery housing and services for individuals with a substance 
use disorder.’’. 
SEC. 1232. DEVELOPING GUIDELINES FOR STATES TO PROMOTE THE 
AVAILABILITY OF HIGH-QUALITY RECOVERY HOUSING. 
Section 550(a) of the Public Health Service Act (42 U.S.C. 
290ee–5(a)) (relating to national recovery housing best practices) 
is amended— 
(1) by amending paragraph (1) to read as follows: 
‘‘(1) IN GENERAL.—The Secretary, in consultation with the 
individuals and entities specified in paragraph (2), shall con-
tinue activities to identify, facilitate the development of, and 
periodically update consensus-based best practices, which may 
include model laws for implementing suggested minimum 
standards for operating, and promoting the availability of, high- 
quality recovery housing.’’; 
(2) in paragraph (2)— 
(A) by striking subparagraphs (A) and (B) and inserting 
the following: 
‘‘(A) officials representing the agencies described in 
subsection (e)(2);’’; 
(B) by redesignating subparagraphs (C) through (G) 
as subparagraphs (B) through (F), respectively; 
(C) in subparagraph (B), as so redesignated, by striking 
‘‘tribal’’ and inserting ‘‘Tribal’’; and 
(D) in subparagraph (D), as so redesignated, by striking 
‘‘tribes, tribal organizations, and tribally’’ and inserting 
‘‘Tribes, Tribal organizations, and Tribally’’; and 
(3) by adding at the end the following: 
‘‘(3) AVAILABILITY.—The best practices referred to in para-
graph (1) shall be— 
‘‘(A) made publicly available; and 
‘‘(B) published on the public website of the Substance 
Abuse and Mental Health Services Administration. 
‘‘(4) EXCLUSION OF GUIDELINE ON TREATMENT SERVICES.— 
In facilitating the development of best practices under para-
graph (1), the Secretary may not include any best practices 
with respect to substance use disorder treatment services.’’. 
SEC. 1233. COORDINATION OF FEDERAL ACTIVITIES TO PROMOTE THE 
AVAILABILITY OF RECOVERY HOUSING. 
Section 550 of the Public Health Service Act (42 U.S.C. 290ee– 
5) (relating to national recovery housing best practices), as amended 
by section 1232, is further amended— 
(1) by redesignating subsections (e), (f), and (g) as sub-
sections (g), (h), and (i), respectively; 
(2) in subsection (c)(2), by striking ‘‘Indian tribes, tribal’’ 
and inserting ‘‘Indian Tribes, Tribal’’; 
(3) in subsection (h)(2), as so redesignated—
H. R. 2617—1217 
(A) by striking ‘‘Indian tribe’’ and inserting ‘‘Indian 
Tribe’’; and 
(B) by striking ‘‘tribal organization’’ and inserting 
‘‘Tribal organization’’; and 
(4) by inserting after subsection (d) the following: 
‘‘(e) COORDINATION OF FEDERAL ACTIVITIES TO PROMOTE THE 
AVAILABILITY
OF
HOUSING
FOR
INDIVIDUALS
EXPERIENCING 
HOMELESSNESS, INDIVIDUALS WITH A MENTAL ILLNESS, AND INDIVID-
UALS WITH A SUBSTANCE USE DISORDER.— 
‘‘(1) IN GENERAL.—The Secretary, acting through the Assist-
ant Secretary, and the Secretary of Housing and Urban 
Development shall convene an interagency working group for 
the following purposes: 
‘‘(A) To increase collaboration, cooperation, and con-
sultation among the Department of Health and Human 
Services, the Department of Housing and Urban Develop-
ment, and the Federal agencies listed in paragraph (2)(B), 
with respect to promoting the availability of housing, 
including high-quality recovery housing, for individuals 
experiencing homelessness, individuals with mental ill-
nesses, and individuals with substance use disorder. 
‘‘(B) To align the efforts of such agencies and avoid 
duplication of such efforts by such agencies. 
‘‘(C) To develop objectives, priorities, and a long-term 
plan for supporting State, Tribal, and local efforts with 
respect to the operation of high-quality recovery housing 
that is consistent with the best practices developed under 
this section. 
‘‘(D) To improve information on the quality of recovery 
housing. 
‘‘(2) COMPOSITION.—The interagency working group under 
paragraph (1) shall be composed of— 
‘‘(A) the Secretary, acting through the Assistant Sec-
retary, and the Secretary of Housing and Urban Develop-
ment, who shall serve as the co-chairs; and 
‘‘(B) representatives of each of the following Federal 
agencies: 
‘‘(i) The Centers for Medicare & Medicaid Services. 
‘‘(ii) The Substance Abuse and Mental Health Serv-
ices Administration. 
‘‘(iii) The Health Resources and Services Adminis-
tration. 
‘‘(iv) The Office of the Inspector General of the 
Department of Health and Human Services. 
‘‘(v) The Indian Health Service. 
‘‘(vi) The Department of Agriculture. 
‘‘(vii) The Department of Justice. 
‘‘(viii) The Office of National Drug Control Policy. 
‘‘(ix) The Bureau of Indian Affairs. 
‘‘(x) The Department of Labor. 
‘‘(xi) The Department of Veterans Affairs. 
‘‘(xii) Any other Federal agency as the co-chairs 
determine appropriate. 
‘‘(3) MEETINGS.—The working group shall meet on a quar-
terly basis. 
‘‘(4) REPORTS TO CONGRESS.—Not later than 4 years after 
the date of the enactment of this section, the working group
H. R. 2617—1218 
shall submit to the Committee on Health, Education, Labor, 
and Pensions, the Committee on Agriculture, Nutrition, and 
Forestry, and the Committee on Finance of the Senate and 
the Committee on Energy and Commerce, the Committee on 
Ways and Means, the Committee on Agriculture, and the Com-
mittee on Financial Services of the House of Representatives 
a report describing the work of the working group and any 
recommendations of the working group to improve Federal, 
State, and local coordination with respect to recovery housing 
and other housing resources and operations for individuals 
experiencing homelessness, individuals with a mental illness, 
and individuals with a substance use disorder.’’. 
SEC. 1234. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND 
MEDICINE STUDY AND REPORT. 
(a) IN GENERAL.—Not later than 60 days after the date of 
enactment of this Act, the Secretary of Health and Human Services, 
acting through the Assistant Secretary for Mental Health and Sub-
stance Use, shall— 
(1) contract with the National Academies of Sciences, 
Engineering, and Medicine— 
(A) to study the quality and effectiveness of recovery 
housing in the United States and whether the availability 
of such housing meets demand; and 
(B) to identify recommendations to promote the avail-
ability of high-quality recovery housing; and 
(2) report to the Congress on the results of such review. 
(b) AUTHORIZATION OF APPROPRIATIONS.—To carry out this sec-
tion, there is authorized to be appropriated $1,500,000 for fiscal 
year 2023. 
SEC. 1235. GRANTS FOR STATES TO PROMOTE THE AVAILABILITY OF 
RECOVERY HOUSING AND SERVICES. 
Section 550 of the Public Health Service Act (42 U.S.C. 290ee– 
5) (relating to national recovery housing best practices), as amended 
by sections 1232 and 1233, is further amended by inserting after 
subsection (e) (as inserted by section 1233) the following: 
‘‘(f) GRANTS FOR IMPLEMENTING NATIONAL RECOVERY HOUSING 
BEST PRACTICES.— 
‘‘(1) IN
GENERAL.—The Secretary shall award grants to 
States (and political subdivisions thereof), Indian Tribes, and 
territories— 
‘‘(A) for the provision of technical assistance to imple-
ment the guidelines and recommendations developed under 
subsection (a); and 
‘‘(B) to promote— 
‘‘(i) the availability of recovery housing for individ-
uals with a substance use disorder; and 
‘‘(ii) the maintenance of recovery housing in accord-
ance with best practices developed under this section. 
‘‘(2) STATE PROMOTION PLANS.—Not later than 90 days after 
receipt of a grant under paragraph (1), and every 2 years 
thereafter, each State (or political subdivisions thereof,) Indian 
Tribe, or territory receiving a grant under paragraph (1) shall 
submit to the Secretary, and publish on a publicly accessible 
internet website of the State (or political subdivisions thereof), 
Indian Tribe, or territory—
H. R. 2617—1219 
‘‘(A) the plan of the State (or political subdivisions 
thereof), Indian Tribe, or territory, with respect to the 
promotion of recovery housing for individuals with a sub-
stance use disorder located within the jurisdiction of such 
State (or political subdivisions thereof), Indian Tribe, or 
territory; and 
‘‘(B) a description of how such plan is consistent with 
the best practices developed under this section.’’. 
SEC. 1236. FUNDING. 
Subsection (i) of section 550 of the Public Health Service Act 
(42 U.S.C. 290ee–5) (relating to national recovery housing best 
practices), as redesignated by section 1233, is amended by striking 
‘‘$3,000,000 for the period of fiscal years 2019 through 2021’’ and 
inserting ‘‘$5,000,000 for the period of fiscal years 2023 through 
2027’’. 
SEC. 1237. TECHNICAL CORRECTION. 
Title V of the Public Health Service Act (42 U.S.C. 290aa 
et seq.) is amended— 
(1) by redesignating section 550 (relating to Sobriety Treat-
ment and Recovery Teams) (42 U.S.C. 290ee–10), as added 
by section 8214 of Public Law 115–271, as section 550A; and 
(2) by moving such section so it appears after section 550 
(relating to national recovery housing best practices). 
CHAPTER 4—SUBSTANCE USE PREVENTION, 
TREATMENT, AND RECOVERY SERVICES BLOCK GRANT 
SEC. 1241. ELIMINATING STIGMATIZING LANGUAGE RELATING TO SUB-
STANCE USE. 
(a) BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUB-
STANCE USE.—Part B of title XIX of the Public Health Service 
Act (42 U.S.C. 300x et seq.) is amended— 
(1) in the part heading, by striking ‘‘SUBSTANCE ABUSE’’ 
and inserting ‘‘SUBSTANCE USE’’; 
(2) in subpart II, by amending the subpart heading to 
read as follows: ‘‘Block Grants for Substance Use Preven-
tion, Treatment, and Recovery Services’’; 
(3) in section 1922(a) (42 U.S.C. 300x–22(a))— 
(A) in paragraph (1), in the matter preceding subpara-
graph (A), by striking ‘‘substance abuse’’ and inserting ‘‘sub-
stance use disorders’’; and 
(B) by striking ‘‘such abuse’’ each place it appears 
in paragraphs (1) and (2) and inserting ‘‘such disorders’’; 
(4) in section 1923 (42 U.S.C. 300x–23)— 
(A) in the section heading, by striking ‘‘SUBSTANCE 
ABUSE’’ and inserting ‘‘SUBSTANCE USE’’; and 
(B) in subsection (a), by striking ‘‘drug abuse’’ and 
inserting ‘‘substance use disorders’’; 
(5) in section 1925(a)(1) (42 U.S.C. 300x–25(a)(1)), by 
striking ‘‘alcohol or drug abuse’’ and inserting ‘‘alcohol or other 
substance use disorders’’; 
(6) in section 1926(b)(2)(B) (42 U.S.C. 300x–26(b)(2)(B)), 
by striking ‘‘substance abuse’’; 
(7) in section 1931(b)(2) (42 U.S.C. 300x–31(b)(2)), by 
striking ‘‘substance abuse’’ and inserting ‘‘substance use dis-
orders’’;
H. R. 2617—1220 
(8) in section 1933(d)(1) (42 U.S.C. 300x–33(d)), in the 
matter following subparagraph (B), by striking ‘‘abuse of alcohol 
and other drugs’’ and inserting ‘‘use of substances’’; 
(9) by amending paragraph (4) of section 1934 (42 U.S.C. 
300x–34) to read as follows: 
‘‘(4) The term ‘substance use disorder’ means the recurrent 
use of alcohol or other drugs that causes clinically significant 
impairment.’’; 
(10) in section 1935 (42 U.S.C. 300x–35)— 
(A) in subsection (a), by striking ‘‘substance abuse’’ 
and inserting ‘‘substance use disorders’’; and 
(B) in subsection (b)(1), by striking ‘‘substance abuse’’ 
each place it appears and inserting ‘‘substance use dis-
orders’’; 
(11) in section 1949 (42 U.S.C. 300x–59), by striking ‘‘sub-
stance abuse’’ each place it appears in subsections (a) and 
(d) and inserting ‘‘substance use disorders’’; 
(12) in section 1954(b)(4) (42 U.S.C. 300x–64(b)(4))— 
(A) by striking ‘‘substance abuse’’ and inserting ‘‘sub-
stance use disorders’’; and 
(B) by striking ‘‘such abuse’’ and inserting ‘‘such dis-
orders’’; and 
(13) in section 1956 (42 U.S.C. 300x–66), by striking ‘‘sub-
stance abuse’’ and inserting ‘‘substance use disorders’’. 
(b) CERTAIN PROGRAMS REGARDING MENTAL HEALTH AND SUB-
STANCE ABUSE.—Part C of title XIX of the Public Health Service 
Act (42 U.S.C. 300y et seq.) is amended— 
(1) in the part heading, by striking ‘‘SUBSTANCE ABUSE’’ 
and inserting ‘‘SUBSTANCE USE’’; 
(2) in section 1971 (42 U.S.C. 300y), by striking ‘‘substance 
abuse’’ each place it appears in subsections (a), (b), and (f) 
and inserting ‘‘substance use’’; and 
(3) in section 1976 (42 U.S.C. 300y–11), by striking ‘‘intra-
venous abuse’’ each place it appears and inserting ‘‘intravenous 
use’’. 
SEC. 1242. AUTHORIZED ACTIVITIES. 
Section 1921(b) of the Public Health Service Act (42 U.S.C. 
300x–21(b)) is amended by striking ‘‘activities to prevent and treat 
substance use disorders’’ and inserting ‘‘activities to prevent, treat, 
and provide recovery support services for substance use disorders’’. 
SEC. 1243. STATE PLAN REQUIREMENTS. 
Section 1932(b)(1)(A) of the Public Health Service Act (42 U.S.C. 
300x–32(b)(1)(A)) is amended— 
(1) by redesignating clauses (vi) through (ix) as clauses 
(vii) through (x), respectively; 
(2) by inserting after clause (v) the following: 
‘‘(vi) provides a description of— 
‘‘(I) 
the 
State’s 
comprehensive 
statewide 
recovery support services activities, including the 
number of individuals being served, target popu-
lations, workforce capacity (consistent with clause 
(viii)), and priority needs; and 
‘‘(II) the amount of funds received under this 
subpart expended on recovery support services, 
disaggregated by the amount expended for type 
of service activity;’’; and
H. R. 2617—1222 
SEC. 1247. STUDY ON ASSESSMENT FOR USE OF STATE RESOURCES. 
(a) IN GENERAL.—The Secretary of Health and Human Services, 
acting through the Assistant Secretary for Mental Health and Sub-
stance Use (in this section referred to as the ‘‘Secretary’’), shall, 
in consultation with States and other local entities providing 
prevention, treatment, or recovery support services related to sub-
stance use, conduct a study on strategies to assess community 
needs with respect to such services in order to facilitate State 
use of block grant funding received under subpart II of part B 
of title XIX of the Public Health Service Act (42 U.S.C. 300x– 
21 et seq.) to provide services to substance use disorder prevention, 
treatment, and recovery support. The study shall, where feasible 
and appropriate, include estimates of resources for community needs 
strategies respective to prevention, treatment, or recovery support 
services. 
(b) REPORT.—Not later than 2 years after the date of enactment 
of this Act, the Secretary shall submit to the Committee on Health, 
Education, Labor, and Pensions of the Senate and the Committee 
on Energy and Commerce of the House of Representatives a report 
on the results of the study conducted under subsection (a). 
CHAPTER 5—TIMELY TREATMENT FOR OPIOID USE 
DISORDER 
SEC. 1251. STUDY ON EXEMPTIONS FOR TREATMENT OF OPIOID USE 
DISORDER THROUGH OPIOID TREATMENT PROGRAMS 
DURING THE COVID–19 PUBLIC HEALTH EMERGENCY. 
(a) STUDY.—The Assistant Secretary for Mental Health and 
Substance Use shall conduct a study, in consultation with patients 
and other stakeholders, on activities carried out pursuant to exemp-
tions granted— 
(1) to a State (including the District of Columbia or any 
territory of the United States) or an opioid treatment program; 
(2) pursuant to section 8.11(h) of title 42, Code of Federal 
Regulations; and 
(3) during the period— 
(A) beginning on the declaration of the public health 
emergency for the COVID–19 pandemic under section 319 
of the Public Health Service Act (42 U.S.C. 247d); and 
(B) ending on the earlier of— 
(i) the termination of such public health emer-
gency, including extensions thereof pursuant to such 
section 319; and 
(ii) the end of calendar year 2022. 
(b) PRIVACY.—The section does not authorize the disclosure 
by the Department of Health and Human Services of individually 
identifiable information about patients. 
(c) FEEDBACK.—In conducting the study under subsection (a), 
the Assistant Secretary for Mental Health and Substance Use shall 
gather feedback from the States and opioid treatment programs 
on their experiences in implementing exemptions described in sub-
section (a). 
(d) REPORT.—Not later than 180 days after the end of the 
period described in subsection (a)(3)(B), and subject to subsection 
(c), the Assistant Secretary for Mental Health and Substance Use 
shall publish a report on the results of the study under this section.
H. R. 2617—1223 
SEC. 1252. CHANGES TO FEDERAL OPIOID TREATMENT STANDARDS. 
(a) MOBILE MEDICATION UNITS.—Section 302(e) of the Con-
trolled Substances Act (21 U.S.C. 822(e)) is amended by adding 
at the end the following: 
‘‘(3) Notwithstanding paragraph (1), a registrant that is dis-
pensing pursuant to section 303(g) narcotic drugs to individuals 
for maintenance treatment or detoxification treatment shall not 
be required to have a separate registration to incorporate one 
or more mobile medication units into the registrant’s practice to 
dispense such narcotics at locations other than the registrant’s 
principal place of business or professional practice described in 
paragraph (1), so long as the registrant meets such standards 
for operation of a mobile medication unit as the Attorney General 
may establish.’’. 
(b) REVISE OPIOID TREATMENT PROGRAM ADMISSION CRITERIA 
TO ELIMINATE REQUIREMENT THAT PATIENTS HAVE AN OPIOID USE 
DISORDER FOR AT LEAST 1 YEAR.—Not later than 18 months after 
the date of enactment of this Act, the Secretary of Health and 
Human Services shall revise section 8.12(e)(1) of title 42, Code 
of Federal Regulations (or successor regulations), to eliminate the 
requirement that an opioid treatment program only admit an indi-
vidual for treatment under the program if the individual has been 
addicted to opioids for at least 1 year before being so admitted 
for treatment. 
CHAPTER 6—ADDITIONAL PROVISIONS RELATING TO 
ADDICTION TREATMENT 
SEC. 1261. PROHIBITION. 
Notwithstanding any provision of this title and the amendments 
made by this title, no funds made available to carry out this 
title or any amendment made by this title shall be used to purchase, 
procure, or distribute pipes or cylindrical objects intended to be 
used to smoke or inhale illegal scheduled substances. 
SEC. 1262. ELIMINATING ADDITIONAL REQUIREMENTS FOR DIS-
PENSING NARCOTIC DRUGS IN SCHEDULE III, IV, AND V 
FOR MAINTENANCE OR DETOXIFICATION TREATMENT. 
(a) IN GENERAL.—Section 303(g) of the Controlled Substances 
Act (21 U.S.C. 823(g)) is amended— 
(1) by striking paragraph (2); 
(2) by striking ‘‘(g)(1) Except as provided in paragraph 
(2), practitioners who dispense narcotic drugs to individuals 
for maintenance treatment or detoxification treatment’’ and 
inserting ‘‘(g) Practitioners who dispense narcotic drugs (other 
than narcotic drugs in schedule III, IV, or V) to individuals 
for maintenance treatment or detoxification treatment’’; 
(3) by redesignating subparagraphs (A), (B), and (C) as 
paragraphs (1), (2), and (3), respectively; and 
(4) in paragraph (2), as so redesignated— 
(A) by striking ‘‘(i) security of stocks’’ and inserting 
‘‘(A) security of stocks’’; and 
(B) by striking ‘‘(ii) the maintenance of records’’ and 
inserting ‘‘(B) the maintenance of records’’. 
(b) CONFORMING CHANGES.—
H. R. 2617—1224 
(1) Subsections (a) and (d)(1) of section 304 of the Controlled 
Substances Act (21 U.S.C. 824) are each amended by striking 
‘‘303(g)(1)’’ each place it appears and inserting ‘‘303(g)’’. 
(2) Section 309A(a)(2) of the Controlled Substances Act 
(21 U.S.C. 829a) is amended— 
(A) in the matter preceding subparagraph (A), by 
striking ‘‘the controlled substance is to be administered 
for the purpose of maintenance or detoxification treatment 
under section 303(g)(2)’’ and inserting ‘‘the controlled sub-
stance is a narcotic drug in schedule III, IV, or V to 
be administered for the purpose of maintenance or detoxi-
fication treatment’’; and 
(B) by striking ‘‘and—’’ and all that follows through 
‘‘is to be administered by injection or implantation;’’ and 
inserting ‘‘and is to be administered by injection or 
implantation;’’. 
(3) Section 520E–4(c) of the Public Health Service Act 
(42 U.S.C. 290bb–36d(c)) is amended by striking ‘‘information 
on any qualified practitioner that is certified to prescribe medi-
cation for opioid dependency under section 303(g)(2)(B) of the 
Controlled Substances Act’’ and inserting ‘‘information on any 
practitioner who prescribes narcotic drugs in schedule III, IV, 
or V of section 202 of the Controlled Substances Act for the 
purpose of maintenance or detoxification treatment’’. 
(4) Section 544(a)(3) of the Public Health Service Act (42 
U.S.C. 290dd–3), as added by section 1219(a)(2), is amended 
by striking ‘‘any practitioner dispensing narcotic drugs pursu-
ant to section 303(g) of the Controlled Substances Act’’ and 
inserting ‘‘any practitioner dispensing narcotic drugs for the 
purpose of maintenance or detoxification treatment’’. 
(5) Section 1833(bb)(3)(B) of the Social Security Act (42 
U.S.C. 1395l(bb)(3)(B)) is amended by striking ‘‘first receives 
a waiver under section 303(g) of the Controlled Substances 
Act on or after January 1, 2019’’ and inserting ‘‘first begins 
prescribing narcotic drugs in schedule III, IV, or V of section 
202 of the Controlled Substances Act for the purpose of mainte-
nance or detoxification treatment on or after January 1, 2021’’. 
(6) Section 1834(o)(3)(C)(ii) of the Social Security Act (42 
U.S.C. 1395m(o)(3)(C)(ii)) is amended by striking ‘‘first receives 
a waiver under section 303(g) of the Controlled Substances 
Act on or after January 1, 2019’’ and inserting ‘‘first begins 
prescribing narcotic drugs in schedule III, IV, or V of section 
202 of the Controlled Substances Act for the purpose of mainte-
nance or detoxification treatment on or after January 1, 2021’’. 
(7) Section 1866F(c)(3) of the Social Security Act (42 U.S.C. 
1395cc–6(c)(3)) is amended— 
(A) in subparagraph (A), by adding ‘‘and’’ at the end; 
(B) in subparagraph (B), by striking ‘‘; and’’ and 
inserting a period; and 
(C) by striking subparagraph (C). 
(8) Section 1903(aa)(2)(C) of the Social Security Act (42 
U.S.C. 1396b(aa)(2)(C)) is amended— 
(A) in clause (i), by adding ‘‘and’’ at the end; 
(B) by striking clause (ii); and 
(C) by redesignating clause (iii) as clause (ii).
H. R. 2617—1225 
SEC. 1263. REQUIRING PRESCRIBERS OF CONTROLLED SUBSTANCES 
TO COMPLETE TRAINING. 
(a) IN GENERAL.—Section 303 of the Controlled Substances 
Act (21 U.S.C. 823) is amended by adding at the end the following: 
‘‘(l) REQUIRED TRAINING FOR PRESCRIBERS.— 
‘‘(1) TRAINING REQUIRED.—As a condition on registration 
under this section to dispense controlled substances in schedule 
II, III, IV, or V, the Attorney General shall require any qualified 
practitioner, beginning with the first applicable registration 
for the practitioner, to meet the following: 
‘‘(A) If the practitioner is a physician (as defined under 
section 1861(r) of the Social Security Act) and the practi-
tioner meets one or more of the following conditions: 
‘‘(i) The physician holds a board certification in 
addiction psychiatry or addiction medicine from the 
American Board of Medical Specialties. 
‘‘(ii) The physician holds a board certification from 
the American Board of Addiction Medicine. 
‘‘(iii) The physician holds a board certification in 
addiction medicine from the American Osteopathic 
Association. 
‘‘(iv) The physician has, with respect to the treat-
ment and management of patients with opioid or other 
substance use disorders, or the safe pharmacological 
management of dental pain and screening, brief inter-
vention, and referral for appropriate treatment of 
patients with or at risk of developing opioid or other 
substance use disorders, completed not less than 8 
hours of training (through classroom situations, semi-
nars at professional society meetings, electronic 
communications, or otherwise) that is provided by— 
‘‘(I) the American Society of Addiction Medi-
cine, the American Academy of Addiction Psychi-
atry, the American Medical Association, the Amer-
ican Osteopathic Association, the American Dental 
Association, the American Association of Oral and 
Maxillofacial Surgeons, the American Psychiatric 
Association, or any other organization accredited 
by the Accreditation Council for Continuing Med-
ical Education (ACCME) or the Commission for 
Continuing 
Education 
Provider 
Recognition 
(CCEPR); 
‘‘(II) any organization accredited by a State 
medical society accreditor that is recognized by 
the ACCME or the CCEPR; 
‘‘(III) any organization accredited by the Amer-
ican Osteopathic Association to provide continuing 
medical education; or 
‘‘(IV) any organization approved by the Assist-
ant Secretary for Mental Health and Substance 
Use, the ACCME, or the CCEPR. 
‘‘(v) The physician graduated in good standing from 
an accredited school of allopathic medicine, osteopathic 
medicine, dental surgery, or dental medicine in the 
United States during the 5-year period immediately 
preceding the date on which the physician first reg-
isters or renews under this section and has successfully
H. R. 2617—1226 
completed a comprehensive allopathic or osteopathic 
medicine curriculum or accredited medical residency 
or dental surgery or dental medicine curriculum that 
included not less than 8 hours of training on— 
‘‘(I) treating and managing patients with 
opioid or other substance use disorders, including 
the appropriate clinical use of all drugs approved 
by the Food and Drug Administration for the treat-
ment of a substance use disorder; or 
‘‘(II) the safe pharmacological management of 
dental pain and screening, brief intervention, and 
referral for appropriate treatment of patients with 
or at risk of developing opioid and other substance 
use disorders. 
‘‘(B) If the practitioner is not a physician (as defined 
under section 1861(r) of the Social Security Act), the practi-
tioner is legally authorized by the State to dispense con-
trolled substances under schedule II, III, IV, or V and 
is dispensing such substances within such State in accord-
ance with all applicable State laws, and the practitioner 
meets one or more of the following conditions: 
‘‘(i) The practitioner has completed not fewer than 
8 hours of training with respect to the treatment and 
management of patients with opioid or other substance 
use disorders (through classroom situations, seminars 
at professional society meetings, electronic communica-
tions, or otherwise) provided by the American Society 
of Addiction Medicine, the American Academy of Addic-
tion Psychiatry, the American Medical Association, the 
American Osteopathic Association, the American 
Nurses Credentialing Center, the American Psychiatric 
Association, the American Association of Nurse Practi-
tioners, the American Academy of Physician Associates, 
or any other organization approved or accredited by 
the Assistant Secretary for Mental Health and Sub-
stance Use or the Accreditation Council for Continuing 
Medical Education. 
‘‘(ii) The practitioner has graduated in good 
standing from an accredited physician assistant school 
or accredited school of advanced practice nursing in 
the United States during the 5-year period immediately 
preceding the date on which the practitioner first reg-
isters or renews under this section and has successfully 
completed a comprehensive physician assistant or 
advanced practice nursing curriculum that included 
not fewer than 8 hours of training on treating and 
managing patients with opioid and other substance 
use disorders, including the appropriate clinical use 
of all drugs approved by the Food and Drug Adminis-
tration for the treatment of a substance use disorder. 
‘‘(2) ONE-TIME TRAINING.— 
‘‘(A) IN
GENERAL.—The Attorney General shall not 
require any qualified practitioner to complete the training 
described in clause (iv) or (v) of paragraph (1)(A) or clause 
(i) or (ii) of paragraph (1)(B) more than once. 
‘‘(B) NOTIFICATION.—Not later than 90 days after the 
date of the enactment of the Restoring Hope for Mental
H. R. 2617—1227 
Health and Well-Being Act of 2022, the Attorney General 
shall provide to qualified practitioners a single written, 
electronic notification of the training described in clauses 
(iv) and (v) of paragraph (1)(A) or clauses (i) and (ii) of 
paragraph (1)(B). 
‘‘(3) RULE OF CONSTRUCTION.—Nothing in this subsection 
shall be construed— 
‘‘(A) to preclude the use, by a qualified practitioner, 
of training received pursuant to this subsection to satisfy 
registration requirements of a State or for some other 
lawful purpose; or 
‘‘(B) to preempt any additional requirements by a State 
related to the dispensing of controlled substances under 
schedule II, III, IV, or V. 
‘‘(4) DEFINITIONS.—In this section: 
‘‘(A) FIRST APPLICABLE REGISTRATION.—The term ‘first 
applicable registration’ means the first registration or 
renewal of registration by a qualified practitioner under 
this section that occurs on or after the date that is 180 
days after the date of enactment of the Restoring Hope 
for Mental Health and Well-Being Act of 2022. 
‘‘(B) QUALIFIED PRACTITIONER.—In this subsection, the 
term ‘qualified practitioner’ means a practitioner who— 
‘‘(i) is licensed under State law to prescribe con-
trolled substances; and 
‘‘(ii) is not solely a veterinarian.’’. 
(b) REPORT.—Not later than 5 years after the date of enactment 
of this Act, the Secretary, in consultation with the Attorney General, 
shall submit to the Committee on Health, Education, Labor, and 
Pensions of the Senate and the Committee on Energy and Com-
merce of the House of Representatives a report assessing the impact 
of the elimination of the waiver program established under section 
303(g)(2) of the Controlled Substances Act (21 U.S.C. 823(g)(2)), 
as amended by the Drug Addiction Treatment Act of 2000. 
SEC. 1264. INCREASE IN NUMBER OF DAYS BEFORE WHICH CERTAIN 
CONTROLLED SUBSTANCES MUST BE ADMINISTERED. 
Section 309A(a)(5) of the Controlled Substances Act (21 U.S.C. 
829a(a)(5)) is amended by striking ‘‘14 days’’ and inserting ‘‘45 
days’’. 
CHAPTER 7—OPIOID CRISIS RESPONSE 
SEC. 1271. OPIOID PRESCRIPTION VERIFICATION. 
(a) MATERIALS FOR TRAINING PHARMACISTS ON CERTAIN CIR-
CUMSTANCES UNDER WHICH A PHARMACIST MAY DECLINE TO FILL 
A PRESCRIPTION.— 
(1) UPDATES TO MATERIALS.—Section 3212(a) of the SUP-
PORT for Patients and Communities Act (21 U.S.C. 829 note) 
is amended by striking ‘‘Not later than 1 year after the date 
of enactment of this Act, the Secretary of Health and Human 
Services, in consultation with the Administrator of the Drug 
Enforcement Administration, Commissioner of Food and Drugs, 
Director of the Centers for Disease Control and Prevention, 
and Assistant Secretary for Mental Health and Substance Use, 
shall develop and disseminate’’ and inserting ‘‘The Secretary 
of Health and Human Services, in consultation with the
H. R. 2617—1228 
Administrator of the Drug Enforcement Administration, 
Commissioner of Food and Drugs, Director of the Centers for 
Disease Control and Prevention, and Assistant Secretary for 
Mental Health and Substance Use, shall develop and dissemi-
nate not later than 1 year after the date of enactment of 
the Restoring Hope for Mental Health and Well-Being Act 
of 2022, and update periodically thereafter’’. 
(2) MATERIALS
INCLUDED.—Section 3212(b) of the SUP-
PORT for Patients and Communities Act (21 U.S.C. 829 note) 
is amended— 
(A) by redesignating paragraphs (1) and (2) as para-
graphs (2) and (3), respectively; and 
(B) by inserting before paragraph (2), as so redesig-
nated, the following new paragraph: 
‘‘(1) pharmacists on how to verify the identity of the 
patient;’’. 
(3) MATERIALS FOR TRAINING ON PATIENT VERIFICATION .— 
Section 3212 of the SUPPORT for Patients and Communities 
Act (21 U.S.C. 829 note) is amended by adding at the end 
the following new subsection: 
‘‘(d) MATERIALS FOR TRAINING ON VERIFICATION OF IDENTITY.— 
Not later than 1 year after the date of enactment of this subsection, 
the Secretary of Health and Human Services, after seeking stake-
holder input in accordance with subsection (c), shall— 
‘‘(1) update the materials developed under subsection (a) 
to include information for pharmacists on how to verify the 
identity of the patient; and 
‘‘(2) disseminate, as appropriate, the updated materials.’’. 
(b) INCENTIVIZING STATES TO BUILD OR MAINTAIN PRESCRIPTION 
DRUG MONITORING PROGRAMS.— 
(1) IN GENERAL.—Section 392A of the Public Health Service 
Act (42 U.S.C. 280b–1) is amended— 
(A) by redesignating subsections (c) and (d) as sub-
sections (d) and (e), respectively; and 
(B) by inserting after subsection (b) the following new 
subsection: 
‘‘(c) PRIORITY.—In awarding grants to States under subsections 
(a) and (b), the Director of the Centers for Disease Control and 
Prevention may give priority to jurisdictions with a disproportion-
ately high rate of drug overdoses or drug overdose deaths, as 
applicable.’’. 
(2) CONFORMING
CHANGE.—Section 392A of the Public 
Health Service Act (42 U.S.C. 280b–1) is amended by striking 
‘‘Indian tribes’’ each place it appears and inserting ‘‘Indian 
Tribes’’. 
SEC. 1272. SYNTHETIC OPIOID AND EMERGING DRUG MISUSE DANGER 
AWARENESS. 
(a) IN GENERAL.—Not later than one year after the date of 
enactment of this Act, the Secretary shall provide for the planning 
and implementation of a public education campaign to raise public 
awareness of synthetic opioids (including fentanyl and its analogues) 
and emerging drug use and misuse issues, as appropriate. Such 
campaign related to synthetic opioids shall include the dissemina-
tion of information that— 
(1) promotes awareness about the potency and dangers 
of fentanyl and its analogues and other synthetic opioids;
H. R. 2617—1229 
(2) explains services provided by the Substance Abuse and 
Mental Health Services Administration and the Centers for 
Disease Control and Prevention (and any entity providing such 
services under a contract entered into with such agencies) 
with respect to the use and misuse of opioids (including syn-
thetic opioids) and other emerging drug threats, such as stimu-
lants, as appropriate; and 
(3) relates generally to opioid use and pain management, 
including information on alternative, nonopioid pain manage-
ment treatments. 
The Secretary shall update such campaign to address emerging 
drug misuse issues, as appropriate. 
(b) USE OF MEDIA.—The campaign under subsection (a) may 
be implemented through the use of television, radio, internet, in- 
person public communications, and other commercial marketing 
venues and may be targeted to specific demographic groups. 
(c) CONSIDERATION
OF REPORT FINDINGS.—In planning and 
implementing the public education campaign under subsection (a) 
related to synthetic opioids, the Secretary shall take into consider-
ation the findings of the report required under section 7001 of 
the SUPPORT for Patients and Communities Act (Public Law 115– 
271). 
(d) CONSULTATION.—In coordinating the campaign under sub-
section (a), the Secretary shall consult with the Assistant Secretary 
for Mental Health and Substance Use to provide ongoing advice 
on the effectiveness of information disseminated through the cam-
paign. 
(e) REQUIREMENT OF CAMPAIGN.—The campaign implemented 
under subsection (a) shall not be duplicative of any other Federal 
efforts relating to eliminating substance use and misuse. 
(f) EVALUATION.— 
(1) IN GENERAL.—The Secretary shall ensure that the cam-
paign implemented under subsection (a) is subject to an inde-
pendent evaluation, beginning 2 years after the date of enact-
ment of this Act, and 2 years thereafter. 
(2) MEASURES
AND
BENCHMARKS.—For purposes of an 
evaluation conducted pursuant to paragraph (1), the Secretary 
shall— 
(A) establish baseline measures and benchmarks to 
quantitatively evaluate the impact of the campaign under 
this section; and 
(B) conduct qualitative assessments regarding the 
effectiveness of strategies employed under this section. 
(g) REPORT.—The Secretary shall, beginning 2 years after the 
date of enactment of this Act, and 2 years thereafter, submit to 
Congress a report on the effectiveness of the campaign implemented 
under subsection (a) towards meeting the measures and benchmarks 
established under subsection (f)(2). 
(h) DISSEMINATION
OF INFORMATION THROUGH PROVIDERS.— 
The Secretary shall develop and implement a plan for the dissemi-
nation of information related to synthetic opioids, to health care 
providers who participate in Federal programs, including programs 
administered by the Department of Health and Human Services, 
the Indian Health Service, the Department of Veterans Affairs, 
the Department of Defense, and the Health Resources and Services 
Administration, the Medicare program under title XVIII of the
H. R. 2617—1230 
Social Security Act (42 U.S.C. 1395 et seq.), and the Medicaid 
program under title XIX of such Act (42 U.S.C. 1396 et seq.). 
(i) TRAINING GUIDE AND OUTREACH ON SYNTHETIC OPIOID EXPO-
SURE PREVENTION.— 
(1) TRAINING GUIDE.—Not later than 18 months after the 
date of enactment of this Act, the Secretary shall design, pub-
lish, and make publicly available on the internet website of 
the Department of Health and Human Services, a training 
guide and webinar for first responders and other individuals 
who also may be at high risk of exposure to synthetic opioids 
that details measures to prevent that exposure. 
(2) OUTREACH.—Not later than 18 months after the date 
of enactment of this Act, the Secretary shall also conduct out-
reach about the availability of the training guide and webinar 
published under paragraph (1) to— 
(A) fire department staff; 
(B) law enforcement officers; 
(C) ambulance transport and other first responders; 
(D) hospital emergency department personnel; and 
(E) other high-risk occupations, as identified by the 
Secretary. 
SEC. 1273. GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO 
OPIOID USE DISORDERS. 
Section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee– 
3 note) is amended to read as follows: 
‘‘SEC. 1003. GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO 
OPIOID USE DISORDERS. 
‘‘(a) IN GENERAL.—The Secretary of Health and Human Services 
(referred to in this section as the ‘Secretary’) shall carry out the 
grant program described in subsection (b) for purposes of addressing 
opioid misuse and use disorders and, as applicable and appropriate, 
stimulant misuse and use disorders, within States, Indian Tribes, 
and populations served by Tribal organizations and Urban Indian 
organizations. 
‘‘(b) GRANTS PROGRAM.— 
‘‘(1) IN GENERAL.—Subject to the availability of appropria-
tions, the Secretary shall award grants to the single State 
agency responsible for administering the substance use preven-
tion, treatment, and recovery services block grant under sub-
part II of part B of title XIX of the Public Health Service 
Act (42 U.S.C. 300x–21 et seq.), Indian Tribes, and Tribal 
organizations for the purpose of addressing opioid misuse and 
use disorders, and as applicable and appropriate, stimulant 
misuse and use disorders, within such States, such Indian 
Tribes, and populations served by such Tribal organizations, 
in accordance with paragraph (2). Indian Tribes or Tribal 
organizations may also apply for an award as part of a consortia 
or may include in an application a partnership with an Urban 
Indian organization. 
‘‘(2) MINIMUM ALLOCATIONS.—Notwithstanding subsection 
(i)(3), in determining grant amounts for each recipient of a 
grant under paragraph (1), the Secretary shall ensure that 
each State and the District of Columbia receive not less than 
$4,000,000 and ensure that each Territory receives not less 
than $250,000. 
‘‘(3) FORMULA METHODOLOGY.—
H. R. 2617—1231 
‘‘(A) IN GENERAL.—At least 30 days before publishing 
a funding opportunity announcement with respect to grants 
under this section, the Secretary shall— 
‘‘(i) develop a formula methodology to be followed 
in allocating grant funds awarded under this section 
among grantees, which, where applicable and appro-
priate based on populations being served by the rel-
evant entity— 
‘‘(I) with respect to allocations for States, gives 
preference to States whose populations have a 
prevalence of opioid misuse and use disorders or 
drug overdose deaths that is substantially higher 
relative to the populations of other States; 
‘‘(II) with respect to allocations for Tribes and 
Tribal organizations, gives preferences to Tribes 
and Tribal organizations (including those applying 
in partnership with an Urban Indian organization) 
serving populations with demonstrated need with 
respect to opioid misuse and use disorders or drug 
overdose deaths; 
‘‘(III) includes performance assessments for 
continuation awards; and 
‘‘(IV) ensures that the formula avoids a 
funding cliff between States with similar overdose 
mortality rates to prevent funding reductions when 
compared to prior year allocations, as determined 
by the Secretary; and 
‘‘(ii) not later than 30 days after developing the 
formula methodology under clause (i), submit the for-
mula methodology to— 
‘‘(I) the Committee on Health, Education, 
Labor, and Pensions and the Committee on Appro-
priations of the Senate; and 
‘‘(II) the Committee on Energy and Commerce 
and the Committee on Appropriations of the House 
of Representatives. 
‘‘(B) REPORT.—Not later than two years after the date 
of the enactment of the Restoring Hope for Mental Health 
and Well-Being Act of 2022, the Comptroller General of 
the United States shall submit to the Committee on Health, 
Education, Labor, and Pensions of the Senate and the 
Committee on Energy and Commerce of the House of Rep-
resentatives a report that— 
‘‘(i) assesses how grant funding is allocated to 
States under this section and how such allocations 
have changed over time; 
‘‘(ii) assesses how any changes in funding under 
this section have affected the efforts of States to 
address opioid misuse and use disorders and, as 
applicable and appropriate, stimulant misuse and use 
disorders; and 
‘‘(iii) assesses the use of funding provided through 
the grant program under this section and other similar 
grant programs administered by the Substance Abuse 
and Mental Health Services Administration.
H. R. 2617—1232 
‘‘(4) USE OF FUNDS.—Grants awarded under this subsection 
shall be used for carrying out activities that supplement activi-
ties pertaining to opioid misuse and use disorders and, as 
applicable and appropriate, stimulant misuse and use disorders 
(including co-occurring substance misuse and use disorders), 
undertaken by the entities described in paragraph (1), which 
may include public health-related activities such as the fol-
lowing: 
‘‘(A) Implementing substance use disorder and overdose 
prevention activities, including primary prevention activi-
ties, and evaluating such activities to identify effective 
strategies 
to 
prevent 
substance 
use 
disorders 
and 
overdoses, which may include drugs or devices approved, 
cleared, or otherwise legally marketed under the Federal 
Food, Drug, and Cosmetic Act. 
‘‘(B) Establishing or improving prescription drug moni-
toring programs. 
‘‘(C) Training for health care practitioners, such as 
best practices for prescribing opioids, pain management, 
recognizing potential cases of substance use disorders, 
referral of patients to treatment programs, preventing 
diversion of controlled substances, and overdose prevention. 
‘‘(D) Supporting access to and the provision of sub-
stance 
use 
disorder-related 
health 
care 
services, 
including— 
‘‘(i) services provided by federally certified opioid 
treatment programs; 
‘‘(ii) services provided in outpatient and residential 
substance use disorder treatment programs or facili-
ties, including those that utilize medication-assisted 
treatment, as appropriate; or 
‘‘(iii) services provided by other appropriate health 
care providers to treat substance use disorders, 
including crisis services and services provided in 
integrated health care settings by appropriate health 
care providers that treat substance use disorders. 
‘‘(E) Recovery support services, including— 
‘‘(i) community-based services that include edu-
cation, outreach, and peer supports such as peer sup-
port specialists and recovery coaches to help support 
recovery; 
‘‘(ii) mutual aid recovery programs that support 
medication-assisted treatment; 
‘‘(iii) services to address housing needs; or 
‘‘(iv) services related to supporting families that 
include an individual with a substance use disorder. 
‘‘(F) Other public health-related activities, as such 
entity determines appropriate, related to addressing opioid 
misuse and use disorders and, as applicable and appro-
priate, stimulant misuse and use disorders, within such 
entity, including directing resources in accordance with 
local needs related to substance use disorders. 
‘‘(c) ACCOUNTABILITY
AND OVERSIGHT.—A State receiving a 
grant under subsection (b) shall submit to the Secretary a descrip-
tion of— 
‘‘(1) the purposes for which the grant funds received by 
the State under such subsection for the preceding fiscal year
H. R. 2617—1233 
were expended and a description of the activities of the State 
under the grant; 
‘‘(2) the ultimate recipients of amounts provided to the 
State; 
‘‘(3) the number of individuals served through the grant; 
and 
‘‘(4) such other information as determined appropriate by 
the Secretary. 
‘‘(d) LIMITATIONS.—Any funds made available pursuant to sub-
section (i) shall not be used for any purpose other than the grant 
program under subsection (b). 
‘‘(e) INDIAN TRIBES
AND TRIBAL ORGANIZATIONS.—The Sec-
retary, in consultation with Indian Tribes and Tribal organizations, 
shall identify and establish appropriate mechanisms for Indian 
Tribes and Tribal organizations to demonstrate or report the 
information as required under subsections (b), (c), and (d). 
‘‘(f) REPORT TO CONGRESS.—Not later than September 30, 2024, 
and biennially thereafter, the Secretary shall submit to the Com-
mittee on Health, Education, Labor, and Pensions of the Senate 
and the Committee on Energy and Commerce of the House of 
Representatives, and the Committees on Appropriations of the 
House of Representatives and the Senate, a report that includes 
a summary of the information provided to the Secretary in reports 
made pursuant to subsections (c) and (d), including— 
‘‘(1) the purposes for which grant funds are awarded under 
this section; 
‘‘(2) the activities of the grant recipients; and 
‘‘(3) each entity that receives a grant under this section, 
including the funding level provided to such recipient. 
‘‘(g) TECHNICAL ASSISTANCE.—The Secretary, including through 
the Tribal Training and Technical Assistance Center of the Sub-
stance Abuse and Mental Health Services Administration, as 
applicable, shall provide entities described in subsection (b)(1) with 
technical assistance concerning grant application and submission 
procedures under this section, award management activities, and 
enhancing outreach and direct support to rural and underserved 
communities and providers in addressing substance use disorders. 
‘‘(h) DEFINITIONS.—In this section: 
‘‘(1) INDIAN
TRIBE.—The term ‘Indian Tribe’ has the 
meaning given the term ‘Indian tribe’ in section 4 of the Indian 
Self-Determination and Education Assistance Act (25 U.S.C. 
5304). 
‘‘(2) TRIBAL ORGANIZATION.—The term ‘Tribal organization’ 
has the meaning given the term ‘tribal organization’ in section 
4 of the Indian Self-Determination and Education Assistance 
Act (25 U.S.C. 5304). 
‘‘(3) STATE.—The term ‘State’ has the meaning given such 
term in section 1954(b) of the Public Health Service Act (42 
U.S.C. 300x–64(b)). 
‘‘(4) URBAN INDIAN ORGANIZATION.—The term ‘Urban Indian 
organization’ has the meaning given such term in section 4 
of the Indian Health Care Improvement Act. 
‘‘(i) AUTHORIZATION OF APPROPRIATIONS.— 
‘‘(1) IN GENERAL.—For purposes of carrying out the grant 
program under subsection (b), there is authorized to be appro-
priated $1,750,000,000 for each of fiscal years 2023 through 
2027.
H. R. 2617—1234 
‘‘(2) FEDERAL ADMINISTRATIVE EXPENSES.—Of the amounts 
made available for each fiscal year to award grants under 
subsection (b), the Secretary shall not use more than 2 percent 
for Federal administrative expenses, training, technical assist-
ance, and evaluation. 
‘‘(3) SET ASIDE.—Of the amounts made available for each 
fiscal year to award grants under subsection (b) for a fiscal 
year, the Secretary shall— 
‘‘(A) award not more than 5 percent to Indian Tribes 
and Tribal organizations; and 
‘‘(B) of the amount remaining after application of 
subparagraph (A), set aside up to 15 percent for awards 
to States with the highest age-adjusted rate of drug over-
dose death based on the ordinal ranking of States according 
to the Director of the Centers for Disease Control and 
Prevention.’’. 
Subtitle C—Access to Mental Health Care 
and Coverage 
CHAPTER 1—IMPROVING UPTAKE AND PATIENT 
ACCESS TO INTEGRATED CARE SERVICES 
SEC. 1301. IMPROVING UPTAKE AND PATIENT ACCESS TO INTEGRATED 
CARE SERVICES. 
Section 520K of the Public Health Service Act (42 U.S.C. 290bb– 
42) is amended to read as follows: 
‘‘SEC. 
520K. 
IMPROVING 
UPTAKE 
AND 
PATIENT 
ACCESS 
TO 
INTEGRATED CARE SERVICES. 
‘‘(a) DEFINITIONS.—In this section: 
‘‘(1) ELIGIBLE ENTITY.—The term ‘eligible entity’ means a 
State, or an appropriate State agency, in collaboration with— 
‘‘(A) 1 or more qualified community programs as 
described in section 1913(b)(1); or 
‘‘(B) 1 or more health centers (as defined in section 
330(a)), rural health clinics (as defined in section 1861(aa) 
of the Social Security Act), or Federally qualified health 
centers (as defined in such section), or primary care prac-
tices serving adult or pediatric patients or both. 
‘‘(2) INTEGRATED CARE; BIDIRECTIONAL INTEGRATED CARE.— 
‘‘(A) The term ‘integrated care’ means collaborative 
models, including the psychiatric collaborative care model 
and other evidence-based or evidence-informed models, or 
practices for coordinating and jointly delivering behavioral 
and physical health services, which may include practices 
that share the same space in the same facility. 
‘‘(B) The term ‘bidirectional integrated care’ means the 
integration of behavioral health care and specialty physical 
health care, and the integration of primary and physical 
health care within specialty behavioral health settings, 
including within primary health care settings. 
‘‘(3) PSYCHIATRIC COLLABORATIVE CARE MODEL.—The term 
‘psychiatric collaborative care model’ means the evidence-based, 
integrated behavioral health service delivery method that 
includes—
H. R. 2617—1235 
‘‘(A) care directed by the primary care team; 
‘‘(B) structured care management; 
‘‘(C) regular assessments of clinical status using 
developmentally appropriate, validated tools; and 
‘‘(D) modification of treatment as appropriate. 
‘‘(4) SPECIAL POPULATION.—The term ‘special population’ 
means— 
‘‘(A) adults with a serious mental illness or adults 
who have co-occurring mental illness and physical health 
conditions or chronic disease; 
‘‘(B) children and adolescents with a serious emotional 
disturbance who have a co-occurring physical health condi-
tion or chronic disease; 
‘‘(C) individuals with a substance use disorder; or 
‘‘(D) individuals with a mental illness who have a 
co-occurring substance use disorder. 
‘‘(b) GRANTS AND COOPERATIVE AGREEMENTS.— 
‘‘(1) IN GENERAL.—The Secretary may award grants and 
cooperative agreements to eligible entities to support the 
improvement of integrated care for physical and behavioral 
health care in accordance with paragraph (2). 
‘‘(2) USE
OF
FUNDS.—A grant or cooperative agreement 
awarded under this section shall be used— 
‘‘(A) to promote full integration and collaboration in 
clinical practices between physical and behavioral health 
care, including for special populations; 
‘‘(B) to support the improvement of integrated care 
models for physical and behavioral health care to improve 
overall wellness and physical health status, including for 
special populations; 
‘‘(C) to promote the implementation and improvement 
of bidirectional integrated care services provided at entities 
described in subsection (a)(1), including evidence-based or 
evidence-informed 
screening, 
assessment, 
diagnosis, 
prevention, treatment, and recovery services for mental 
and substance use disorders, and co-occurring physical 
health conditions and chronic diseases; and 
‘‘(D) in the case of an eligible entity that is collabo-
rating with a primary care practice, to support the 
implementation of evidence-based or evidence-informed 
integrated care models, including the psychiatric collabo-
rative care model, including— 
‘‘(i) by hiring staff; 
‘‘(ii) by identifying and formalizing contractual 
relationships with other health care providers or other 
relevant entities offering care management and behav-
ioral health consultation to facilitate the adoption of 
integrated care, including, as applicable, providers who 
will function as psychiatric consultants and behavioral 
health care managers in providing behavioral health 
integration services through the collaborative care 
model; 
‘‘(iii) by purchasing or upgrading software and 
other resources, as applicable, needed to appropriately 
provide 
behavioral 
health 
integration, 
including 
resources needed to establish a patient registry and 
implement measurement-based care; and